Correlation Between Partners Value and Appili Therapeutics

Can any of the company-specific risk be diversified away by investing in both Partners Value and Appili Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Partners Value and Appili Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Partners Value Investments and Appili Therapeutics, you can compare the effects of market volatilities on Partners Value and Appili Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Partners Value with a short position of Appili Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Partners Value and Appili Therapeutics.

Diversification Opportunities for Partners Value and Appili Therapeutics

0.0

Correlation Coefficient

Partners Value  Appili Therapeutics

Pay attention - limited upside

The 3 months correlation between Partners and Appili is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Partners Value Investments and Appili Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Appili Therapeutics and Partners Value is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Partners Value Investments are associated (or correlated) with Appili Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Appili Therapeutics has no effect on the direction of Partners Value i.e., Partners Value and Appili Therapeutics go up and down completely randomly.

Pair Corralation between Partners Value and Appili Therapeutics

Assuming the 90 days trading horizon Partners Value Investments is expected to under-perform the Appili Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Partners Value Investments is 2.07 times less risky than Appili Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Appili Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1.50  in Appili Therapeutics on July 24, 2025 and sell it today you would earn a total of  1.50  from holding Appili Therapeutics or generate 100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Partners Value Investments  vs.  Appili Therapeutics

Partners Value Inves

Risk-Adjusted Performance

Weakest

Over the last 90 days Partners Value Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Appili Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Appili Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Appili Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Partners Value and Appili Therapeutics

The main advantage of trading using opposite Partners Value and Appili Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Partners Value position performs unexpectedly, Appili Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will offset losses from the drop in Appili Therapeutics' long position.

The idea behind Partners Value Investments and Appili Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.